Quantcast

Latest Generic drug Stories

2014-08-29 12:24:42

PISCATAWAY, N.J., Aug. 29, 2014 /PRNewswire/ -- InnoPharma, Inc. today announced the approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for decitabine for injection, a generic version of Eisai Inc.'s DACOGEN®. InnoPharma developed the generic formulation of decitabine for injection and entered into an agreement with Sandoz, Inc., pursuant to which Sandoz will sell, market and distribute decitabine for injection in the United...

2014-08-28 23:10:26

The NAPSRX has received a small grant and awarded the 2014 Kennedy Educational Award in Washington, D.C. to support the future establishment and implementation of advanced Pharmaceutical Sales Vocational Education. Washington, DC (PRWEB) August 28, 2014 The NAPSRx announced today that it has received a small grant and awarded the 2014 Kennedy Educational Award in Washington, D.C. to support the future establishment and implementation of advanced Pharmaceutical Sales Vocational Educational...

2014-08-28 12:29:56

PITTSBURGH, Aug. 28, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its abbreviated new drug application (ANDA) for a three times per week Glatiramer Acetate Injection 40 mg/mL has been accepted for filing by the U.S. Food and Drug Administration (FDA). This product is the generic version of Teva's Copaxone® 40 mg/mL, which is indicated for the treatment of patients with relapsing forms of multiple sclerosis (MS)....

2014-08-27 12:30:26

Profit Attributable to Owners of the Company Up by 34.4% HONG KONG, Aug. 27, 2014 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical company with the largest cardio-cerebral vascular ("CCV") drug franchise in China's prescription drug market, today announced the unaudited consolidated results of the Company and its subsidiaries (collectively the "Group") for the six months ended 30 June 2014...

2014-08-24 23:00:47

Over the five-year period, many thin film drug manufacturers will focus on developing a drug pipeline that encompasses more therapeutic classes, such as drugs that treat respiratory-related ailments. For these reasons, industry research firm IBISWorld has updated a report on the Thin Film Drug Manufacturing industry in its growing industry report collection. New York, NY (PRWEB) August 24, 2014 Over the past five years, the Thin Film Drug Manufacturing industry has exhibited rapid revenue...

2014-08-22 23:08:21

For generic drugmakers, Oct. 1 is crunch time and is the date after which all ANDA amendment and prior-approval supplement applications must meet new performance goals under the Generic Drug User Fee Amendments (GDUFA) of 2012. Joan Janulis, a Hatch-Waxman pro and all-around expert on FDA regulation in the generic drug industry, will help attendees read between the lines of the GDUFA performance metrics, associated guidance documents and MAPPs, and provide a roadmap to the post-GDUFA...

2014-08-22 16:23:24

DUBLIN, Aug. 22, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Rotigotine Extended-release Transdermal Film, 1 mg/24 hr, 2mg/24 hr, 3 mg/24hr, 4 mg/24 hr, 6mg/24hr, and 8 mg/24 hr. Actavis' ANDA product is a generic version of UCB's Neupro(®), which is indicated for the treatment of signs and symptoms of idiopathic Parkinson's...

2014-08-19 08:29:01

MUMBAI, August 19, 2014 /PRNewswire/ -- 'Weight Loss- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014', report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries and regions. While the leading brands, companies and chemicals are...

2014-08-18 12:27:41

DUBLIN, Aug. 18, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "The Overveiw of Japanese Generic Drug Market" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 This report talks about the overview of Japanese generic drug market. It gives the readers ann understanding of the overall climate surrounding generic market in Japan. The report covers related regulations, generics's share in Japan, market size, primary makers, market trend,...

2014-08-11 08:28:44

PITTSBURGH, Aug. 11, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has launched Capecitabine Tablets USP, 150 mg and 500 mg, the generic version of Genentech's Xeloda® Tablets. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is indicated as monotherapy, adjuvant therapy and combination therapy for certain types of breast, colon and colorectal cancers.(1) CEO...


Word of the Day
bodacious
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'
Related